Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Vaniqa Could Surface By Early 2005

Executive Summary

Women First HealthCare may explore Rx-to-OTC switch opportunities forVaniqa facial hair growth retardation cream as early as 2004, the firm stated
Advertisement

Related Content

Gillette Mach3 Turbo Revs Up Q2 Blade And Razor Sales
Gillette Mach3 Turbo Revs Up Q2 Blade And Razor Sales
Clairol $50 Mil. Marketing Boost Part Of P&G Blueprint For Growth
Vaniqa Rx Facial Hair Remover May Be Strong OTC Switch Candidate
Vaniqa Rx Facial Hair Remover May Be Strong OTC Switch Candidate
Advertisement
UsernamePublicRestriction

Register

RS010418

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel